ARCHIVES

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

Conferees Agree On 6,200 Grants For NIH This Year

August 2, 1985

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

NCI-Approved Clinical Trials

January 27, 2006

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

March 1, 1991

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

2018 State of Cancer Care in America

February 3, 2022